Preclinical models demonstrate potential to restore thymic function lost with aging reducing susceptibility to cancer, autoimmune diseases, infections, and reduced vaccine efficacyHOUSTON, April 10, ...

A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen receptor T-cell therapies in autoimmune and rheumatic diseases.“It is quite ...

Cancers that were once considered incurable now have new treatment options. Among these innovations are CAR-T (chimeric ...

CAR-T therapy has transformed treatment for some blood cancers, with seven FDA-approved products and strong clinical responses in hematologic malignancies.

CAR-T cell therapy represents an innovative form of immunotherapy, wherein T cells are genetically modified to recognize and ...

Within the evolving landscape of peptide science, Thymosin Alpha-1 occupies a distinctive conceptual position. First characterized decades ago as a thymus-associated peptide fragment, it has since bee ...

After a decade-long quest to fill a major gap in basic biology, UChicago scientists have built a complete map of how cells ...

Cancer biology research increasingly recognizes the profound heterogeneity and plasticity of cancer cells. These cells can transition dynamically between ...